Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Comment by gaserx2on Jan 21, 2014 1:35pm
342 Views
Post# 22116471

RE:RE:RE:BNN

RE:RE:RE:BNNCsondNvestR...Yes perhaps a somewhat negative asessment, however as a shareholder and similarily as any management official of any corporation might do you every now and again express your frustration and concern with the velocity of progress. I, in no way am saying that the hard work of the BC Cancer agency is not appreciated and has gone unnoticed. I do wonder though how they as an agency of the BC Ministry of Health did not have constructive consultation with them, to ensure that such an extraordinay innovative medical device would not be immediately accepted and implemented by the BC Medical Industry in some form or the other. Perhaps my lack of a clear understanding of the medical industry logistics and total functionality as to how technology is asessed and applied where and when as needed to the Health Care system.

That said I have been a shareholder of VRS since February of 2011 and my average cost is .65 cents. I as well am a longterm shareholder and will continue as such until we have achieved the success it rightly deserves. But even the most insightly shareholders and astute investors would surely at some point have to question how and why we have not progressed further than we have, after a very successful introduction to the marketplace some 3 years ago.  It is my hope and desire that they truely succeed in their efforts. IMHO.

Bullboard Posts